Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03356366

MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis

Magnetic Resonance Imaging Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multiple sclerosis (MS) is the first non-traumatic cause of disability in young people, responsible for physical but also cognitive deficits. MS is an inflammatory demyelinating and degenerative disease of the central nervous system. Recently, MRI technics have demonstrated their sensibility to the different processes involved in MS. Particularly, MRI has evidenced that the pathological process of MS is not restricted to the macroscopic lesions of the white matter but also involves the normal appearing white and grey matter. In the normal appearing brain tissue, demyelination, neuronal suffering and neuronal loss have been evidenced. Moreover, MRI has demonstrated the existence of brain functional reorganization processes that may limit the clinical expression of pathological injuries. Despite these important findings, the pathological underpinnings of irreversible disability are largely unknown. The present project aims to depict the main determinants of physical but also cognitive disability in patients with MS. To do this, a longitudinal study including 70 patients with MS using different MRI markers known to be sensitive to the different pathological aspects of MS will be performed. The relationships between these markers and the progression of disability will be assessed. Identification of the main pathological underpinnings of irreversible disability of MS will provide the most relevant therapeutic targets.

Conditions

Interventions

TypeNameDescription
OTHERMRI 3TMagnetic Resonance Imaging 3 Tesla
OTHERMRI 1,5TMagnetic Resonance Imaging 1,5 Tesla
OTHERMRI 7TMagnetic Resonance Imaging 7 Tesla

Timeline

Start date
2017-10-02
Primary completion
2023-01-16
Completion
2028-12-31
First posted
2017-11-29
Last updated
2024-08-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03356366. Inclusion in this directory is not an endorsement.